Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
1-Minute Consult

What is the hepatitis B vaccination regimen in chronic kidney disease?

Kheng Yong Ong, BSc (Pharm) (Hons), Hong Yun Wong, BSc (Pharm) (Hons) and Giat Yeng Khee, PharmD
Cleveland Clinic Journal of Medicine January 2018, 85 (1) 32-34; DOI: https://doi.org/10.3949/ccjm.85a.17017
Kheng Yong Ong
Pharmacist, Department of Pharmacy, Singapore General Hospital, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
Hong Yun Wong
Pharmacist, Department of Pharmacy, Khoo Teck Puat Hospital, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giat Yeng Khee
Senior Clinical Pharmacist. Department of Pharmacy, Singapore General Hospital, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

    • View popup
    TABLE 1

    Recommended vaccination regimens for hepatitis B virus in chronic kidney disease

    VaccineRegimen
    Recombivax-HB40 μg intramuscularly, at 0, 1, and 6 months
    Engerix-B40 μg (ie, double the standard 20-μg dose) intramuscularly, at 0, 1, 2, and 6 months
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 85 (1)
Cleveland Clinic Journal of Medicine
Vol. 85, Issue 1
1 Jan 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
What is the hepatitis B vaccination regimen in chronic kidney disease?
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
What is the hepatitis B vaccination regimen in chronic kidney disease?
Kheng Yong Ong, Hong Yun Wong, Giat Yeng Khee
Cleveland Clinic Journal of Medicine Jan 2018, 85 (1) 32-34; DOI: 10.3949/ccjm.85a.17017

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
What is the hepatitis B vaccination regimen in chronic kidney disease?
Kheng Yong Ong, Hong Yun Wong, Giat Yeng Khee
Cleveland Clinic Journal of Medicine Jan 2018, 85 (1) 32-34; DOI: 10.3949/ccjm.85a.17017
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • RECOMMENDED DOSES AND SCHEDULES
    • MONITORING THE RESPONSE TO VACCINATION AND REVACCINATION
    • ANTIBODY PERSISTENCE AND BOOSTER DOSES
    • OTHER WAYS TO IMPROVE VACCINE RESPONSE
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • My adult patient’s hypercholesterolemia is not responding to statins—what’s next?
  • Should I start anticoagulation in my patient newly diagnosed with pulmonary hypertension?
  • Does my adult patient need a measles vaccine?
Show more 1-Minute Consult

Similar Articles

Subjects

  • Hepatology
  • Infectious Diseases
  • Nephrology
  • Preventive Care

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire